25/06/2020

Scaling vaccine procurement

Each year, UNICEF supplies over two billion doses of vaccines , to reach approximately 45 per cent of the world’s children under five years of age. This annual investment, totaling $1.656 billion in 2019, supports routine immunization programmes, preventive campaigns and outbreak response around the world.  Over the past few decades, the vaccine…, Case study IPV: the fastest introduction and scale up of a vaccine ever, but not without challenges, In an effort to accelerate the global eradication of polio and help prevent a resurgence of the disease, WHO recommended in 2013 that all countries introduce at least one dose of inactivated polio vaccine (IPV) into routine immunization schedules by the end of 2015. At the time, 126 countries were using only oral polio vaccine (OPV). By the end of…, Case study Making PCV available, affordable and in pace with demand, First licensed in 2000, the pneumococcal conjugate vaccine (PCV) prevents pneumococcal diseases (such as pneumonia or meningitis) – a leading cause of mortality in children. In 2007, WHO issued a recommendation that countries include PCV in their national immunization programmes, however uptake was low due to various factors, including price. To…, Case study Navigating complex supply constraints to meet HPV vaccine demand, First licensed in 2006, human papillomavirus (HPV) vaccines to protect against cervical cancer were recommended by WHO as a part of national immunization programmes in 2009. In 2012, Gavi began support for HPV vaccine demonstration programmes, and further broadened its programme policy in 2016 to increase uptake. The new guidelines allowed…